Nuclear Medicine

What Is Nuclear Medicine?

Nuclear Medicine is a specialized branch of medicine that uses small amounts of radioactive substances, known as radiopharmaceuticals or radiotracers, to evaluate how organs and tissues function. Unlike imaging methods that primarily show anatomy, nuclear medicine can provide information about biological and metabolic activity, helping doctors identify abnormal changes and assess how a disease is behaving.

Depending on the clinical requirement, nuclear medicine may be used for diagnosis, disease staging, treatment planning, treatment response assessment, and selected targeted therapies. Common technologies include PET-CT, SPECT, SPECT-CT and gamma camera imaging.

PET-CT and Molecular Imaging

A PET-CT scan combines positron emission tomography (PET) with computed tomography (CT). PET provides information about metabolic or molecular activity, while CT provides detailed anatomical information. Combining these images can help physicians locate and characterize areas of abnormal activity more precisely.

PET-CT is widely used in oncology for evaluating many types of cancer, including assessment of disease extent and treatment response. Depending on the clinical indication, different radiotracers may be selected. For example, FDG is commonly used for many cancer imaging applications, while specialized tracers such as PSMA may be used in selected prostate cancer evaluations.

SPECT and SPECT-CT Scans

SPECT (Single-Photon Emission Computed Tomography) uses a gamma camera to create three-dimensional images showing the distribution of a radiotracer in the body. When combined with CT, SPECT-CT can provide both functional and anatomical information.

SPECT-based nuclear medicine imaging may be used to evaluate several organs and systems, including the heart, bones, kidneys, thyroid, lungs, gastrointestinal system and brain. Specific tests are selected according to the patient's symptoms and medical condition.

Common Nuclear Medicine Scans

Depending on the patient's clinical needs, nuclear medicine imaging may include:

• PET-CT scans for metabolic and molecular imaging
• Bone scans to assess bone metabolism and selected skeletal conditions
• Thyroid and parathyroid scans for functional evaluation
• Renal scans to assess kidney function and drainage
• Cardiac nuclear medicine scans for evaluating blood flow and heart function
• Lung perfusion scans for selected pulmonary conditions
• Hepatobiliary and gastrointestinal scans
• Lymphoscintigraphy and sentinel lymph node imaging
• Selected brain and neurological nuclear medicine studies

The exact examination depends on the suspected condition and the information required by the treating physician.

Nuclear Medicine Treatment

Nuclear medicine is not limited to diagnostic imaging. Certain radiopharmaceuticals can also be used therapeutically to deliver radiation to specific tissues or disease targets.

Examples include radioactive iodine treatment for selected thyroid conditions and cancers, as well as targeted radiopharmaceutical therapies used for certain prostate cancers and neuroendocrine tumors. These treatments are planned according to the patient's diagnosis, imaging findings, laboratory results and overall clinical condition.

Theranostics in Nuclear Medicine

Theranostics combines diagnostic imaging and targeted radiopharmaceutical treatment. A diagnostic radiotracer can help identify whether a particular molecular target is present, while a related therapeutic radiopharmaceutical may then be considered for appropriately selected patients.

This approach is increasingly used in specialized cancer care, including selected PSMA-targeted therapies for prostate cancer and peptide receptor radionuclide therapy (PRRT) for certain neuroendocrine tumors. Eligibility depends on individual clinical and imaging findings.

What to Expect During a Nuclear Medicine Scan

The preparation and duration of a nuclear medicine procedure vary depending on the type of scan. In many examinations, a small amount of radiopharmaceutical is administered through an injection, by mouth, or through another appropriate route. The tracer is then allowed time to reach the organs or tissues being evaluated before images are acquired.

For PET imaging, for example, an intravenous radiotracer such as FDG may be administered, followed by a waiting period before scanning. Patients are generally asked to remain still during image acquisition so that clear images can be obtained.

Preparation for Nuclear Medicine Procedures

Preparation varies considerably between examinations. Depending on the test, patients may be asked to:

• Follow specific fasting instructions
• Drink water or remain well hydrated
• Avoid certain foods, medicines or strenuous activity
• Bring previous reports or relevant medical records
• Inform the nuclear medicine team about current medications
• Inform the healthcare team about pregnancy or possible pregnancy
• Inform the team if breastfeeding

Patients should follow the specific preparation instructions provided by their nuclear medicine department because requirements differ between PET-CT, SPECT, thyroid studies and therapeutic procedures.

Radiation Safety in Nuclear Medicine

Nuclear medicine uses carefully selected amounts of radiopharmaceuticals, with the administered activity determined according to the clinical purpose and other patient-specific factors. Radiation protection principles are used to keep exposure as low as reasonably achievable while obtaining the necessary diagnostic information.

After some procedures, patients may receive temporary precautions relating to close contact, hygiene, fluid intake or other activities. These instructions depend on the radiopharmaceutical and whether the procedure was diagnostic or therapeutic. Patients should follow the individualized safety instructions provided by their healthcare team.

Nuclear Medicine for Cancer Care

Nuclear medicine in cancer care can provide functional and molecular information that complements conventional imaging. PET-CT and specialized molecular imaging techniques may help doctors evaluate suspected disease, stage certain cancers, identify areas of active disease and assess response to treatment.

Some radiopharmaceuticals can also be used to deliver targeted radiation to selected cancer cells. The choice of imaging or therapy depends on the cancer type, molecular characteristics, previous treatment and individual patient factors.

Who May Need Nuclear Medicine?

A doctor may recommend a nuclear medicine procedure when information about organ function, metabolism, blood flow or molecular activity could help with diagnosis or treatment planning.

Depending on the examination, nuclear medicine may play a role in evaluating:

• Cancer and suspected cancer recurrence
• Thyroid and parathyroid disorders
• Heart and blood-flow conditions
• Bone and joint abnormalities
• Kidney function
• Selected lung conditions
• Neuroendocrine tumors
• Prostate cancer
• Certain neurological conditions
• Other disorders requiring functional or molecular imaging

Not every patient with these conditions requires nuclear medicine. The appropriate test is determined by the treating physician based on the patient's clinical history and diagnostic needs.

Nuclear Medicine: Diagnosis and Treatment in One Specialty

Modern nuclear medicine brings together functional imaging, molecular diagnostics and targeted radiopharmaceutical treatment. From PET-CT and SPECT imaging to radioactive iodine therapy and theranostic approaches, these techniques can provide information that complements conventional diagnostic methods.

Patients should discuss the purpose of the recommended examination, preparation requirements, potential benefits and any precautions with their treating physician or nuclear medicine specialist before undergoing a procedure.